期刊文献+

药物诱发的心房颤动 被引量:5

Atrial fibrillation induced by drugs
下载PDF
导出
摘要 心房颤动是一种常见的心律失常。心房颤动的发生常有其基础病因和促发因素。许多药物,如心血管系统药物、呼吸系统药物、抗肿瘤药物、中枢神经系统药物等可诱发心房颤动的发生。 Atrial fibrillation (AF) is a common arrhythmia. The attack of AF has its fundamental cause and trigger. Many drugs, such as cardiovascular drugs, respiratory drugs, antineoplastic drugs, central nervous system drugs, etc., may induce the occurrence of AF.
作者 黄震华
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2006年第7期556-559,共4页 Chinese Journal of New Drugs and Clinical Remedies
关键词 心房颤动 心血管药物 呼吸系统药 抗肿瘤药 中枢神经系统药物 药物不良反应 atrial fibrillation cardiovascular agents respiratory system agents antineoplastic agents central nervous system agents adverse drug reactions
  • 相关文献

参考文献22

  • 1GO AS, HYLEK EM, CHANG Y, et al. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trial translate into clinical practice?[J]. JAMA, 2003, 290( 20 ) : 2685-2692. 被引量:1
  • 2BORIANI G, DIEMBERGER I, BIFFI M, et al. Pharmacological cardioversion of atrial fibrillation: current management and treatment options[J]. Drugs, 2004, 64 (24) : 2741-2762. 被引量:1
  • 3BORIANI G, BIFFI M, DIEMBERGER I, et al. Rate control in atrial fibrillation : choice of treatment and assessment of efficacy [J]. Drugs, 2003, 63(14) : 1489-1509. 被引量:1
  • 4ALLESSIE MA, BOYDEN PA, CAMM AJ, et al. Pathophysiology and prevention of atrial fibrillation[J]. Circulation,2001,103(5) :769-777. 被引量:1
  • 5CHUGH SS, BLACKSHEAR JL, SHEN WK, et al. Epidemiology and natural history of atrial fibrillation: clinical implications[J]. J Am Coll Cardiol, 2001,37(2) :371-378. 被引量:1
  • 6HART RG, PEARCE LA, ROTHBART RM, et al. Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators [J]. J Am Coll Cardiol, 2000,35 ( 1 ) : 183-187. 被引量:1
  • 7GUPTA AK, MAHESHWARI A, TRESCH DD, et al. Cardiac arrhythmias in the elderly [J]. Card Electrophysiol Rev, 2002, 6(1-2) : 120-128. 被引量:1
  • 8FUSTER V, RYDEN LE, ASINGER RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary:a report of the American College of Cardiology/American Heart Association Task Force on Practiceand the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences(Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation):developed in collaboration with the North American Society of Pacing and Electrophysiology [J]. Circulation, 2001,104 (17) :2118-2150. 被引量:1
  • 9van der HOOFT CS, HEERINGA J, van HERPEN G, et al.Drug-induced atrial fibrillation [J]. J Am Coil Cardiol, 2004,(11 ) :2117-2124. 被引量:1
  • 10CHAUDHRY GM, HAFFAJEE CI. Antiarrhythmic agents and proarrhythmia[J]. Crit Care Med,2000,28( 10 Suppl ) : 158-164. 被引量:1

同被引文献19

  • 1魏昌华,姚春芳,恽榴红.新型抗癌药──紫杉醇[J].中国药学杂志,1996,31(5):259-263. 被引量:57
  • 2王屏,卜一珊.药源性心律失常156例统计分析[J].中国药事,2006,20(2):127-128. 被引量:6
  • 3于亚平.抗肿瘤药物的心脏毒性[J].现代肿瘤医学,2006,14(12):1628-1630. 被引量:11
  • 4国家药典委员会.中国药典临床用药须知[M].北京:化学工业出版社,2001.702-704. 被引量:2
  • 5Perez EA.Paclitaxel and cardiotoxicity[J].J clin Oncol,1998,16 (11):3481. 被引量:1
  • 6Santini D,Tonini G,Abbate A,et al.Gemcitabine-in-duced atrial fibrillatan:a hitherto unreported manifestation of drug toxicity[J].Ann Oncol,2000,11 (4):479. 被引量:1
  • 7WYSE DG,WALDO AL,DI MARCO JP,et al.A comparison of rate control and rhythm control in patients with atrial fibrillation[J].N Engl J Med,2002,347(23):1825-1833. 被引量:1
  • 8BORIANI G,DIEMBERGER I,BIFFI M,et al.Pharmacological cardioversion of atrial fibrillation:current management and treatment options[J].Drugs,2004,64(24):2741-2762. 被引量:1
  • 9ALLESSIE MA,BOYDEN PA,CAMM AJ,et al.Pathophysiology and prevention of atrial fibrillation[J].Circulation,2001,103(5):769-777. 被引量:1
  • 10KHAN IA.Transient atrial mechanical dysfunction(stunning) after cardioversion of atrial fibrillation and flutter[J].Am Heart J,2002,144(2):232. 被引量:1

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部